Advertisement
UK markets close in 3 hours 8 minutes
  • FTSE 100

    8,229.13
    -18.66 (-0.23%)
     
  • FTSE 250

    20,340.23
    -23.20 (-0.11%)
     
  • AIM

    766.70
    -1.33 (-0.17%)
     
  • GBP/EUR

    1.1839
    +0.0002 (+0.01%)
     
  • GBP/USD

    1.2661
    -0.0026 (-0.20%)
     
  • Bitcoin GBP

    48,546.22
    +285.56 (+0.59%)
     
  • CMC Crypto 200

    1,276.08
    -7.70 (-0.60%)
     
  • S&P 500

    5,469.30
    +21.43 (+0.39%)
     
  • DOW

    39,112.16
    -299.05 (-0.76%)
     
  • CRUDE OIL

    81.39
    +0.56 (+0.69%)
     
  • GOLD FUTURES

    2,327.00
    -3.80 (-0.16%)
     
  • NIKKEI 225

    39,667.07
    +493.92 (+1.26%)
     
  • HANG SENG

    18,089.93
    +17.03 (+0.09%)
     
  • DAX

    18,132.56
    -45.06 (-0.25%)
     
  • CAC 40

    7,596.55
    -65.75 (-0.86%)
     

Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

HERCULES, Calif., May 23, 2024--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 10:30 AM Eastern Time (7:30 AM Pacific Time).

A live webcast and subsequent replay of the event will be available in the Investor Relations section of Bio-Rad’s website at bio-rad.com.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 8,000 employees and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.

ADVERTISEMENT

View source version on businesswire.com: https://www.businesswire.com/news/home/20240523594442/en/

Contacts

Investor Contact:
Edward Chung, Investor Relations
510-741-6104
ir@bio-rad.com

Media Contact:
Anna Gralinska, Corporate Communications
510-741-6643
cc@bio-rad.com